AI Tool Comparison
OpenEvidence vs Claude
An objective side-by-side comparison based on global rankings, AI scores, and monthly user data.
Higher Ranked
OpenEvidence
Research & SearchAI clinical evidence search engine that helps physicians find answers from medical literature.
AI Score27.1 / 100
#610
Global Rank
–
Monthly Users
VS
Higher Ranked
Claude
Writing & ChatAnthropic's AI assistant for analysis, long-form writing, coding, and complex reasoning.
AI Score80.3 / 100
#72
Global Rank
60M+
Monthly Users
Side-by-Side Comparison
| OpenEvidence | Claude | |
|---|---|---|
| Category | Research & Search | Writing & Chat |
| Global Rank | #610 | #72 |
| AI Score | 27.1/100 | 80.3/100 |
| Monthly Users | – | 60M+ |
| Pricing | Free | Freemium |
| Website | openevidence.com | claude.ai |
Pros & Cons
OpenEvidence
- Genuinely free for verified US healthcare professionals, funded entirely by advertising
- Massive real-world adoption — approximately 20 million clinical consultations/month as of January 2026
- Substantial recent funding ($250M Series D, $12B valuation) suggests continued platform investment
- Access requires a US NPI number, excluding non-US healthcare professionals
- Withdrew from the EU and UK entirely in April 2026, cutting off previous international access
- Ad-supported model means pharmaceutical advertising is shown during use
Claude
- Widely regarded as one of the strongest options for coding and complex reasoning tasks
- Large context window handles long documents and codebases well
- Writing tone is often considered more natural than competing assistants
- Projects and Artifacts features support organized, ongoing work
- Smaller consumer ecosystem and fewer third-party integrations than ChatGPT
- Free tier has tighter usage limits than some competitors
- Fewer built-in consumer features like native voice mode compared to some competitors
- Brand recognition outside technical and professional circles remains lower than ChatGPT’s